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Rapid diagnostic tests (RDTs) are less reliant on expert microscopy and have the potential to reduce errors
in malaria diagnosis but have not been extensively evaluated in nonimmune persons or in countries where
infection is not endemic. We evaluated the ICT P.f/P.v (ICT-Amrad, Sydney, Australia) and OptiMal (Flow
Inc., Portland, Oreg.) assays prospectively for the diagnosis of malaria in 158 specimens from 144 febrile
returned travellers in Australia by using expert microscopy and PCR as reference standards. Malaria was
diagnosed in 93 specimens from 87 patients by expert microscopy, with 3 additional specimens from recently
treated patients testing positive for Plasmodium falciparum by PCR. For the diagnosis of asexual-stage P. fal-
ciparum malaria, the sensitivity and specificity of the ICT P.f/P.v assay were 97 and 90%, respectively, and those
of the OptiMal assay were 85 and 96%, respectively. The ICT P.f/P.v assay missed one infection with a density of
45 parasites/l, whereas the OptiMal assay missed infections up to 2,500/l; below 1,000/l, its sensitivity was
only 43%. For the diagnosis of P. vivax malaria, the sensitivity and specificity of the ICT P.f/P.v assay were 44
and 100%, respectively, and those of the OptiMal assay were 80 and 97%, respectively. Both assays missed in-
fections with parasite densities over 5,000/l: up to 10,000/l with the former and 5,300/l with the latter. Des-
pite the high sensitivity of the ICT P.f/P.v assay for P. falciparum malaria, caution is warranted before RDTs are
widely adopted for the diagnosis of malaria in nonimmune patients or in countries where malaria is not endemic.
Although regions with endemic infection incur most of the
burden of malaria-associated morbidity and mortality, the in-
fection also presents a considerable problem in other coun-
tries. Cases of imported malaria have increased in Western
countries over the past several decades (6, 20) and are related
to increased international travel and immigration. Given that
80% or more of travelers who contract malaria do not develop
symptoms until returning home (2, 13), the diagnosis of ma-
laria generally depends on laboratories in areas where infec-
tion is not endemic. However, in such settings, expertise in
malaria diagnosis is often limited and, consequently, diagnostic
inaccuracies are a well-recognized problem (2, 13, 16). Mor-
tality from imported malaria, primarily due to Plasmodium
falciparum, is 0.6 to 3.8%, (5, 20; H. O. Lobel, C. C. Campbell,
and J. M. Roberts, Letter, Lancet i:873, 1985) and is strongly
associated with delays in diagnosis and institution of appropri-
ate treatment (5, 19, 31). Strategies to improve the accuracy
and timeliness of malaria diagnosis, particularly where exper-
tise in microscopy is limited, are thus priorities.
Microscopy remains the diagnostic technique of choice for
malaria. It is relatively inexpensive, sensitive to a threshold of
5 to 50 parasites/l (depending on technical factors such as the
expertise of the microscopist) (17, 33), and able to characterize
the infecting species and their relative densities. However, it
requires considerable technical expertise for optimal blood
film preparation, examination, and interpretation. Immuno-
capture rapid diagnostic tests (RDTs) based on the detection
of malarial antigens have been developed to improve the time-
liness, sensitivity, and objectivity of malaria diagnosis, through
less reliance on expert microscopy. The ParaSight-F (Becton
Dickinson, Franklin Lakes, N.J). and ICT P.f (Amrad-ICT,
Sydney, Australia) assays detect the histidine-rich protein 2
(HRP2) antigen of the asexual stages and young gametocytes
of P. falciparum and have a detection threshold of around 40
to 60 parasites/l and an overall sensitivity of 84 to 100% for
P. falciparum infections (17, 24, 27, 29, 34). Two other recently
developed RDTs can detect P. vivax in addition to P. falci-
parum. The ICT P.f/P.v assay (Amrad-ICT) detects the same
P. falciparum-specific HRP2 antigen as the ICT P.f assay and a
panmalarial antigen expressed by P. falciparum, P. vivax, and
possibly also P. ovale and P. malariae (D. P. Mason, C. Wong-
srichanalai, K. Lin, R. S. Miller, and F. Kawamoto, Letter,
J. Clin. Microbiol. 39:2035, 2001). The OptiMal assay (Flow
Inc., Portland, Oreg.) detects Plasmodium-specific lactate de-
hydrogenase (pLDH) antigens that are expressed by both sex-
ual and asexual parasitic stages, one P. falciparum specific and
one Plasmodium genus specific (23). From limited evaluations,
both assays appear sensitive for the detection of P. falciparum
infections but variable for non-falciparum infections (1, 3, 7–9,
12, 18, 21, 24, 27, 29).
These RDTs, however, have a number of important limita-
tions, including suboptimal sensitivity at low parasite densities,
an inability to accurately identify parasites to the species level
or to quantify infection density, and a higher unit cost relative
to microscopy. False-positive results occur with HRP2-based
assays because of antigen persistence for up to 28 days despite
clearance of asexual-stage parasites with chemotherapy (15),
and they occur with both HRP2- and pLDH-based assays in
the presence of rheumatoid factor (10; A. Bartoloni, G. Saba-
tinelli, and M. Benucci, Letter, N. Engl. J. Med. 338:1075,
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1998; M. P. Grobusch, U. Alpermann, S. Schwenke, T. Jelinek,
and D. C. Warhurst, Letter, Lancet 353:297, 1999). Despite
these limitations, RDTs are a potentially useful adjunct to
microscopy, particularly where expertise is limited, and have
been adopted in laboratories in many countries where infec-
tion is not endemic. In Australia, 43% of laboratories par-
ticipating in the Royal Australasian College of Pathologists
quality assurance program for malaria diagnosis routinely use
RDTs to supplement microscopy (S. Neville, personal commu-
nication). The performance characteristics of such assays, how-
ever, have not been extensively established for febrile returned
travelers.
The objective of this study was to determine prospectively
the performance characteristics of two recently developed RDTs
(ICT P.f/P.v and OptiMal) in the diagnosis of malaria in febrile
patients presenting in New South Wales, Australia. Reference
standards used for comparison were expert microscopy and
PCR.
(The work cited in this paper was presented in part at the
2001 Australian Society for Microbiology Annual Scientific
Meeting, Perth, Australia, 30 September to 5 October 2001
[abstract PP7.1].)
MATERIALS AND METHODS
Study setting. The study was undertaken at the Institute for Clinical Pathology
and Medical Research in Sydney, Australia. The Parasitology Department pro-
vides both a primary diagnostic service for locally referred specimens and a
reference service for malaria diagnosis for the state of New South Wales.
Study design and specimens. Consecutive specimens submitted to the Parasi-
tology Department from August 2000 to June 2001 were included in the study;
these comprised specimens referred directly from medical practitioners and
those referred secondarily from other laboratories in New South Wales for
confirmation. Inclusion in the study required the availability of thick blood films
and the primary whole-blood specimen (collected in EDTA) stored at 2 to 8°C.
Microscopy (J.W.), PCR (E.G.P.), and the RDTs (M.A.) were performed in
parallel on all specimens by separate experienced operators blinded to the results
of the other assays. All identifying details were removed from specimens after
allocation of a study number, and the results were correlated after completion of
all assays.
Microscopy. Thick and thin films were prepared from primarily referred
whole-blood specimens and stained with Field’s stain by standard procedures
within 1 h of receipt (32). Blood films submitted from other laboratories were
examined as submitted (if stained) or were stained with Field’s stain. A micros-
copist with more than 30 years of experience examined each thick film for at least
20 min under a 40 oil immersion lens (total magnification, 500) such that at
least 200 to 300 fields were examined. The parasite density was calculated with
reference to the white cell count measured from simultaneously drawn blood and
was expressed as the number of parasites per microliter (26).
PCR assay. DNA was extracted from 200 l of whole blood using the QIAamp
DNA mini kit (Qiagen, Clifton Hill, Victoria, Australia) as specified by the
manufacturer. Extracted DNA was amplified in a seminested multiplex PCR
assay using primers targeting the small ribosomal subunit gene, allowing the
simultaneous detection and identification to the species level of malaria species
as previously described (25). Bands were visualized on a 2% agarose gel after
electrophoresis at 200 V for 40 min. Contamination control measures included
the use of dedicated equipment in separate laboratory areas for each assay step
as well as other standard measures (14). A negative control was included for each
specimen, and a positive control (incorporating a mixture of all four malaria
species) was included for each assay run.
Rapid diagnostic tests. Each whole-blood specimen was tested immediately on
receipt by using the ICT P.f/P.v and OptiMal assays as specified by the manu-
facturers. The RDTs were stored at 4°C until use. Both assays were considered
valid if the control line was visible. For the ICT P.f/P.v assay, a visible HRP2 line
was interpreted as indicating infection with P. falciparum and a visible panma-
larial antigen line was interpreted as indicating infection with P. vivax. Where
both the HRP2 and the panmalarial antigen lines were visible, P. falciparum
infection was diagnosed, although this is also consistent with a mixed infection
with P. falciparum and another malaria species. For the OptiMal test, where both
the P. falciparum-specific and the panmalarial pLDH lines were visible, infection
with P. falciparum was diagnosed, although this is also consistent with a mixed
infection as above. A visible panmalarial pLDH line was interpreted as infection
with P. vivax.
Reference standards. Following validation against microscopy, PCR was used
as the reference standard for the diagnosis of all malaria, P. falciparum (all
stages) malaria, P. vivax malaria, and non-falciparum malaria. Since PCR cannot
differentiate between sexual and asexual P. falciparum parasites, microscopy was
used as the reference standard for the diagnosis of asexual-stage P. falciparum
infection.
Statistical analysis. Specimens were classified as true positive, true negative,
false positive, or false negative for each test under evaluation compared with the
reference standard. Sensitivity, specificity, positive and negative predictive val-
ues, and likelihood ratios (LRs) for positive and negative test results were
calculated (4). Comparison of independent means was performed using a
two-sample t test, and comparison of independent proportions was performed
using a 2 test. All significance tests were two tailed. Data were analyzed
using EpiInfo version 6 and Minitab for Windows release 12 (Minitab Inc.,
State College, Pa.).
RESULTS
General characteristics and microscopy of study specimens.
During the study period, 158 specimens from 144 patients were
tested by microscopy, PCR, and the two RDTs. Of the study
patients, 96 were males, and the median age was 31 years
(range, 1 to 75 years).
Microscopy was positive for 93 specimens from 88 episodes
of malaria in 87 patients (Table 1). Of the infections, 28 were
acquired in the Pacific region (mostly Papua New Guinea), 27
were acquired in Africa, 21 were acquired in Southeast Asia
(mostly East Timor), 11 were acquired in southern Asia (most-
ly from the Indian subcontinent), and 1 was acquired in South
America.
P. falciparum parasites were detected in 37 specimens (from
35 patients). Asexual-stage (with or without sexual-stage) par-
asites were present in 33 specimens (from 31 patients) at den-
sities of 5 to 992,000/l (median, 4,830/l; interquartile range,
500 to 27,000/l); one specimen also contained P. vivax para-
sites. Four specimens (from four patients) contained only sex-
ual-stage parasites; one also contained P. ovale parasites.
P. vivax parasites were detected in 52 specimens (from 49 pa-
tients) at densities of 14 to 28,500 parasites/l (median, 2,970/
TABLE 1. Comparison of the results of microscopy and PCRa
Result by
microscopy
No. of specimens with following
result by PCR: Total no. of
specimens
PF PM PO PV PF/PV PF/PO NEG
PF (asexual stages) 32 32
PF (sexual stage only) 3 3
PM 2 2
PO 3 3
PV 1 50 51
PFb/PV 1 1
PFc/PO 1 1
NEG 3 62 65
Total no. of specimens 38 2 4 50 1 1 62 158
a PF, P. falciparum; PM, P. malariae; PO, P. ovale; PV, P. vivax; PF/PV, mixed
P. falciparum and P. vivax; PF/PO, mixed P. falciparum and P. ovale; NEG,
negative.
b Asexual-stage  sexual-stage P. falciparum parasites.
c Sexual-stage P. falciparum parasites only.
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l; interquartile range, 690 to 7,080/l). P. ovale was detected
in four specimens (from four patients; densities, 630 to 16,930/
l), and P. malariae was detected in two specimens (from two
patients; densities, 340 and 770/l).
Comparison of PCR with microscopy. Microscopy and PCR
were concordant for 155 (98%) of 158 specimens for the de-
tection of malaria parasites (Table 1). The three discrepant
specimens were PCR positive for P. falciparum but microscopy
negative. Although no parasites were detected after repeated
microscopic examination, these specimens probably repre-
sented true-positive results by PCR since they were obtained
after initiation of treatment for microscopy-confirmed P. falci-
parum infection. Microscopy and PCR results were concordant
for the identification to the species level of malaria parasites in
92 (99%) of 93 specimens in which parasites were detected by
both techniques. The single discrepancy was identified as P.
ovale by PCR but P. vivax by microscopy; subsequent blinded
review of the blood film by microscopy favored a diagnosis of
P. ovale.
Comparison of RDTs with PCR and microscopy. The per-
formance of the RDTs compared with the reference standards
of PCR and microscopy is presented in Tables 2 and 3. The
median duration of whole-blood storage at 2 to 8°C until per-
formance of the RDTs was 2 days (range, 0 to 12 days).
For the diagnosis of P. falciparum infections (all stages), the
ICT P.f/P.v assay was significantly more sensitive than the
OptiMal assay (97.5 and 75%, respectively; 21  8.54, P 
0.003). It was also more sensitive for asexual-stage P. falcipa-
rum infections (97 and 84.8%, respectively), but the difference
was not statistically significant (21  2.92, P  0.09). The only
false-negative result with the ICT P.f/P.v assay was a specimen
with a parasite density of 45/l (Table 4). False-negative re-
sults, however, occurred with the OptiMal assay up to parasite
densities of 2,500/l; below this level, only 62% of infections
were detected, and for infections at less than 1,000/l, only
43% were detected (Table 4). The ICT P.f/P.v and OptiMal
assays were positive for all seven and one of seven specimens,
respectively, with only sexual stages of P. falciparum or that
were PCR positive but microscopy negative.
The ICT P.f/P.v assay performed poorly for the diagnosis of
P. vivax infection (sensitivity, 44%); false-negative results oc-
curred at parasite densities up to 10,000/l, and below this
level only 33% of infections were detected (Table 4). Although
the OptiMal assay was significantly more sensitive than the
ICT P.f/P.v assay (sensitivity, 80%; 21  13.8, P  0.001),
false-negative results still occurred at parasite densities up to
5,300/l. The ICT P.f/P.v assay failed to detect any of the
P. ovale and P. malariae infections, whereas the OptiMal assay
TABLE 2. Comparison of the results of the ICT P.f/P.v and OptiMal assays with PCRa
Result by PCR
No. of specimens with following
result by ICT P.f/P.v: Total no. of
specimens
No. of specimens with following
result by OptiMal: Total no. of
specimens
PF PV NEG PF PV NEG
PF 37 1 38 28 10 38
PM 2 2 2 2
PO 4 4 3 1 4
PV 22 28 50 2 40 8 50
PF/PV 1 1 1 1
PF/PO 1 1 1 1
NEG 2 60 62 1 61 62
Total no. of specimens 41 22 95 158 33 43 82 158
a See Materials and Methods for interpretation of the ICT P.f/P.v and OptiMal assays. Abbreviations are as in Table 1.
TABLE 3. Performance characteristics of ICT P.f/P.v and OptiMal compared with PCR and microscopy
Assay Result by PCR ormicroscopya
% Sensitivity
(95% CI)d
% Specificity
(95% CI)
% Positive predictive
value (95% CI)
% Negative predictive
value (95% CI)
LR for:
Positive
test
Negative
test
ICT P.f/P.v assay Any parasite 63.5 (53.1–73.1) 96.8 (88.8–99.6) 96.8 (89.0–99.6) 63.2 (52.6–72.8) 19.8 0.37
PFb (all stages) 97.5 (86.8–99.9) 98.3 (94.0–99.7) 95.1 (83.5–99.4) 99.1 (95.3–99.9) 57.4 0.03
PFb (asexual stages) 97.0 (84.2–99.9) 90.4 (83.8–94.9) 78.1 (62.3–89.4) 99.1 (95.3–99.9) 10.1 0.03
PVc 44 (30.0–58.7) 100 (96.6–100) 100 (84.6–100) 79.4 (71.6–85.9)  0.61
Non-PFc 39.3 (26.5–53.2) 100 (96.6–100) 100 (84.6–100) 76.1 (68.2–82.8)  0.61
Optimal assay Any parasite 78.1 (68.5–85.9) 98.4 (91.3–99.9) 98.7 (92.9–99.9) 74.4 (63.6–83.4) 48.8 0.22
PFb (all stages) 75.0 (58.8–87.3) 97.5 (92.7–99.5) 90.9 (75.7–98.1) 92.0 (85.8–96.1) 30 0.26
PFb (asexual stages) 84.8 (68.1–94.9) 96.0 (90.9–98.7) 84.8 (68.1–94.9) 96.0 (90.9–98.7) 21.2 0.16
PVc 80.0 (66.3–90.0) 97.2 (92.1–99.4) 93.0 (80.9–98.5) 91.3 (84.6–95.8) 28.5 0.21
Non-PFc 76.8 (63.6–87.0) 100 (96.5–100) 100 (91.8–100) 88.7 (81.4–93.8)  0.23
a Microscopy was used as the reference standard for calculating the performance characteristics for asexual-stage P. falciparum infection; PCR was used for all other
diagnoses (see Materials and Methods).
b Includes mixed infections.
c Excludes mixed infections; non-PF, all non-falciparum infections.
d CI, confidence interval.
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detected three of four P. ovale infections but neither of the
P. malariae infections.
The ICT P.f/P.v assay produced false-positive P. falciparum
results in two PCR-negative specimens, whereas the OptiMal
assay produced P. falciparum false-positive results in one PCR-
negative specimen and two specimens containing only P. vivax
parasites. No specimen gave a false-positive result in both
assays. Clinical follow-up did not suggest recent or subsequent
P. falciparum malaria in patients with false-positive results.
Based on recorded intervals between specimen collection
and testing, there was no evidence that false-negative or false-
positive results were related to a delay in performing RDTs.
DISCUSSION
The diagnosis of malaria may be challenging for laboratories
in countries where infection is not endemic, such that inaccu-
racies are relatively common (2, 13, 16). Immunocapture
RDTs that detect circulating malaria antigens have the poten-
tial to improve the accuracy and timeliness of malaria diagno-
sis, particularly in areas where expertise in microscopy is lim-
ited. Given that delays in the diagnosis and institution of
treatment for malaria are important and potentially avoidable
contributors to malaria-associated mortality (5, 19, 31), such
improvements are important priorities. Although the ICT P.f
and ParaSight assays are generally highly sensitive and specific
for P. falciparum infection (17, 22, 28, 30, 34), they are unable
to detect non-falciparum species. The recently developed ICT
P.f/P.v and OptiMal assays can detect both P. falciparum and
non-falciparum species but have not been extensively evalu-
ated, particularly in nonimmune persons. We evaluated the
performance characteristics of these two assays for malaria
diagnosis in febrile travelers returning to a country where in-
fection is not endemic. The study was designed to evaluate
consecutive specimens prospectively, using the reference stan-
dards of expert microscopy and PCR as reference standards,
with independent operators performing each assay while
blinded to the other results.
The ICT P.f/P.v assay was highly sensitive (97%) for the
diagnosis of clinically significant P. falciparum infections (i.e.,
those with asexual-stage parasites), consistent with previously
published evaluations of the assay in its current and previous
formats (17, 24, 27, 29). It demonstrated a low detection
threshold, although only two specimens with parasite densities
of 100/l were assessed. However, the assay performed
particularly poorly in diagnosing P. vivax malaria (sensitiv-
ity, 44%), with false-negative results encountered for infec-
tions with densities up to 10,000 parasites/l. These results
are considerably inferior to those in other reports from coun-
tries with endemic infection (27, 29), possibly reflecting the
lower parasite densities encountered in infected nonimmune
patients.
On the other hand, the OptiMal assay demonstrated only
moderate sensitivity for both P. falciparum and non-falciparum
malaria, generally consistent with previous reports (7, 8, 12, 18,
21). False-negative results occurred with P. falciparum malaria
at densities up to 2,500 parasites/l and with P. vivax malaria at
densities up to 5,300/l.
The specificities of both assays were generally high, despite
the occurrence of occasional false-positive P. falciparum detec-
tions. In addition, the specificity of the ICT P.f/P.v assay for
asexual-stage P. falciparum infections suffered from the detec-
tion of all seven clinically insignificant infections (i.e., those
that contained only sexual-stage P. falciparum parasites or that
were PCR positive and microscopy negative).
LRs can be used to quantitate the impact of either a positive
or a negative test result on the pretest disease probability; from
knowledge of the LR and an estimate of the pretest probabil-
ity, the posttest probability can be derived directly or with a
nomogram (11). Thus, LRs are of greater practical value for
clinicians as performance parameters of diagnostic tests than
are sensitivity, specificity, and predictive values. In general,
large and generally conclusive changes in disease probability
are produced by tests with LRs greater than 10 or less than 0.1
(11). From this study, both assays have LRs for a positive test
result greater than 10 for all malarial diagnoses (Table 3); a
positive test result thus makes the likelihood of malaria very
high across a wide range of pretest probabilities. In contrast,
TABLE 4. Sensitivities of the ICT P.f/P.v and OptiMal assays for the diagnosis of asexual-stage P. falciparum and
P. vivax infections, stratified by parasite densitya
Infection type and parasite
density (parasites/l)
ICT P.f/P.v OptiMAL
No. of specimens % Sensitivity
(95% CI)
No. of specimens % Sensitivity
(95% CI)PF PV NEG PF PV NEG
P. falciparum (asexual stage)
100 1 0 1 50 (13–99) 0 0 2 0 (0–84)
100–1,000 5 0 0 100 (48–100) 3 0 2 60 (15–95)
1,000–10,000 11 0 0 100 (72–100) 10 0 1 91 (59–100)
	10,000 15 0 0 100 (78–100) 15 0 0 100 (78–100)
Total 32 0 1 97.0 (84.2–99.9) 28 0 5 84.8 (68.1–94.8)
P. vivax
100 0 0 3 0 (0–71) 0 1 2 33 (8–91)
100–1,000 0 1 13 7 (0–34) 0 10 4 71 (42–92)
1,000–10,000 0 13 12 52 (31–72) 2 21 2 84 (64–96)
	10,000 0 8 0 100 (63–100) 0 8 0 100 (63–100)
Total 0 22 28 44.0 (30.0–58.7) 2 40 8 80.0 (66.3–90.0)
a Abbreviations are as in Tables 1 and 3.
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with one exception, the LRs for a negative test result with both
assays are greater than 0.2; a negative test result therefore does
not substantially alter the pretest disease probability. However,
with an LR of 0.03, a negative ICT P.f/P.v assay result would
virtually exclude the diagnosis of asexual-stage P. falciparum
malaria. This study used expert microscopy and PCR as refer-
ence standards. The concordance of these standards was high;
the only discrepancies involved three post-treatment speci-
mens in which P. falciparum was detected by PCR but not by
microscopy and one misidentification of P. ovale as P. vivax by
microscopy. Although PCR is an impractical primary diagnos-
tic technique because of the turnaround time, expense, and
technical expertise required, its accuracy makes it an important
reference standard for evaluating new diagnostic assays.
RDTs have the potential to improve the accuracy and time-
liness of malaria diagnosis, particularly for laboratories in
countries without endemic infection, where expertise with mi-
croscopy may be limited. Consequently, such assays are becom-
ing increasingly utilized in such settings. Given that malaria in
nonimmune returned travelers is generally associated with low-
level parasitemias of between 50 and 5,000/l (17), the rela-
tively poor performance characteristics of RDTs at these den-
sities demands caution regarding their use in nonimmune
infected persons. The incremental utility of RDTs over non-
reference microscopy in countries without endemic infection
has also not been evaluated; such an evidence-based approach
is required before their application can be widely recom-
mended. On the basis of the published evaluations of these
assays, the most rational potential application of RDTs in
countries without endemic infection would be where expert
microscopy is unavailable for the detection or exclusion of
P. falciparum parasites in suspicious negative blood films or in
the presence of a non-falciparum species. However, the latter
situation is uncommon in Australia, since mixed infections with
P. falciparum constituted only 21 (1.4%) of 1,473 malaria no-
tifications in Australia during 1992 to 1993 (2). Therefore, we
think that the results of this study emphasize that microscopy
should remain the diagnostic technique of choice for malaria
diagnosis in nonimmune patients and that they also emphasize
the importance of close links with a reference microscopy
service where expertise is limited such as in countries where
infection is not endemic. The accuracy and utility of RDTs
require further investigation before their widespread adoption
in such settings can be recommended.
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